Targeting the CD73-adenosine axis in immuno-oncology

Immunology Letters
David AllardJohn Stagg

Abstract

The ectonucleotidases CD39 and CD73 are cell surface enzymes that catabolize the breakdown of extracellular ATP into adenosine. As such, they constitute critical components of the extracellular purinergic pathway and play important roles in maintaining tissue and immune homeostasis. With the coming of age of cancer immunotherapy, ectonucleotidases and adenosine receptors have emerged as novel therapeutic targets to enhance antitumor immune responses. With early-phase clinical trials showing promising results, it is becoming increasingly important to decipher the distinct mechanisms-of-action of adenosine-targeting agents, identify patients that will benefit from these agents and rationally develop novel synergistic combinations. Given the broad expression of ectonucleotidases and adenosine receptors, a better understanding of cell-specific roles will also be key for successful implementation of this new generation of immuno-oncology therapeutics. We here review the latest studies on the roles of CD73 and adenosine in cancer with a focus on cell-specific function. We also discuss ongoing clinical trials and future avenues for adenosine-targeting agents.

References

Apr 29, 1998·Immunological Reviews·R RestaL F Thompson
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li YangTim R Mosmann
Aug 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Akio OhtaMichail Sitkovsky
May 16, 2007·The Journal of Experimental Medicine·Silvia DeaglioSimon C Robson
Jun 26, 2007·Clinical & Experimental Metastasis·Xiuling ZhiLianhua Yin
Oct 27, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Sirpa Jalkanen, Marko Salmi
Jan 21, 2009·Cell Research·Jian XuRik Derynck
Oct 28, 2009·The Journal of Biological Chemistry·Magis MandapathilTheresa L Whiteside
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Dec 7, 2010·Cellular Signalling·Randi Mosenden, Kjetil Taskén
May 4, 2011·The Journal of Clinical Investigation·Long WangBin Zhang
Jun 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aled ClaytonZsuzsanna Tabi
Jan 31, 2012·Journal of Surgical Oncology·Xian-Rui WuPing Lan
Mar 8, 2012·Cancer Research·John StaggMark J Smyth
May 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julie S NielsenBrad H Nelson
May 4, 2012·Applied Immunohistochemistry & Molecular Morphology : AIMM·Anna SupernatAnna Zaczek
Jun 2, 2012·British Journal of Cancer·C Lo NigroT Crook
Apr 10, 2013·World Journal of Gastroenterology : WJG·Xiao-Xia LuXiao-Yuan Chu
May 9, 2013·Pathology Oncology Research : POR·Qing YangLingling Zu
Jun 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sherene LoiJohn Stagg
Aug 29, 2013·International Journal of Cancer. Journal International Du Cancer·Bertrand AllardJohn Stagg
Aug 29, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bertrand AllardJohn Stagg
Dec 3, 2013·The Journal of Clinical Investigation·Geok Choo SimLaszlo Radvanyi
Jul 6, 2014·Cancer Research·Deepak MittalMark J Smyth
Jul 6, 2014·Cancer Immunology Research·Michail V SitkovskyAkio Ohta
Aug 17, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergey V RyzhovSergey V Novitskiy
Feb 14, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bin ZhangGuo-En Fang
Apr 15, 2015·The Journal of Experimental Medicine·Lili JingLeonard I Zon
Jun 21, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabio MorandiFabio Malavasi

❮ Previous
Next ❯

Citations

Dec 6, 2018·International Journal of Molecular Sciences·Kevin SekPaul A Beavis
May 1, 2020·Cancer Immunology, Immunotherapy : CII·J H AzambujaE Braganhol
Apr 23, 2020·Journal of Cell Science·Karolina LosenkovaGennady G Yegutkin
May 30, 2019·International Journal of Molecular Sciences·Yaara Gorzalczany, Ronit Sagi-Eisenberg
Jun 22, 2019·Immunotherapy·Siqi ChenBin Zhang
Nov 20, 2019·International Journal of Molecular Sciences·Juliana Hofstätter AzambujaTheresa L Whiteside
Dec 22, 2019·Purinergic Signalling·Kelly Juliana FilippinEdgar J Paredes-Gamero
Apr 27, 2019·Frontiers in Immunology·Simone de LeveVerena Jendrossek
Oct 19, 2019·Cancers·Simone de LeveVerena Jendrossek
May 5, 2020·Oncoimmunology·Nouredin MessaoudiSimon Turcotte
Jul 11, 2020·Journal of Cellular Physiology·Sheng WangXiongwen Lv
Sep 10, 2020·Asia-Pacific Journal of Clinical Oncology·Hye Ryeon ChoiYoung-Ju Jeong
Jun 10, 2020·Nature Reviews. Clinical Oncology·Bertrand AllardJohn Stagg
Oct 22, 2020·International Journal of Molecular Sciences·Deborah PietrobonoMaria Letizia Trincavelli
Oct 31, 2020·Frontiers in Immunology·Orazio FortunatoGiulia Bertolini
Feb 13, 2020·Cancer Immunology Research·Erik WennerbergSandra Demaria
Oct 31, 2020·The Journal of Biological Chemistry·James E StefanoKatarina Radošević
Dec 20, 2020·Biochemical Pharmacology·Gennady G Yegutkin
Oct 31, 2020·Signal Transduction and Targeted Therapy·Yuqing CaoFeng Xu
Jan 7, 2021·Cancers·Antonio Lopez-BeltranRodolfo Montironi
Feb 12, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jaehyun KimYong-Hee Kim
Jan 18, 2021·The Journal of Biological Chemistry·James E StefanoKatarina Radošević
Feb 23, 2021·Frontiers in Pharmacology·Anna Lisa GiulianiFrancesco Di Virgilio
Mar 16, 2021·Oncoimmunology·Samuel T WorkenheGuido Kroemer
Mar 31, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Amanda de Fraga DiasFabrício Figueiró
Apr 4, 2021·International Journal of Molecular Sciences·Laura BeneckeLaurent Muller
Apr 29, 2021·Expert Opinion on Therapeutic Patents·Alessio NocentiniClaudiu T Supuran
Apr 30, 2021·Purinergic Signalling·Dominique S RubenichElizandra Braganhol
Apr 27, 2021·Nature Cancer·Mark EspositoYibin Kang
Jun 24, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lisa EhlersTimo Gaber
Jul 11, 2021·Life Sciences·Shahin HallajFarhad Jadidi-Niaragh
Mar 22, 2019·Journal of Medicinal Chemistry·Anna JunkerKenneth A Jacobson
Nov 13, 2019·Journal of Chemical Information and Modeling·Lucas G VivianiAntonia T-do Amaral
Aug 24, 2021·Frontiers in Immunology·Valentina AudritoSilvia Deaglio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Immunology and Cell Biology
David AllardJohn Stagg
International Journal of Molecular Sciences
Kevin SekPaul A Beavis
Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Jiao Wang, Sandro Matosevic
© 2022 Meta ULC. All rights reserved